Dupixent Approved as First Biologic for COPD in Japan
March 28, 2025
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Regeneron
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Regeneron
Mediaplanet, announces the launch of Lung Health. Chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and other lung conditions affect millions worldwide, yet many remain unaware
Fuel up with free Health Tech Insights